GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) » Definitions » Valuation Rank

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Valuation Rank


View and export this data going back to 2021. Start your Free Trial

What is Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Youlian 1st Street, 13th Floor, Jinniu District, Sichuan Province, Chengdu, CHN, 610081
Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd provides convenient, efficient and low-cost medical circulation services for the vast community medical terminals and primary medical institutions. It offers various products such as respiratory system, cardiovascular and neurological drugs, biological product, rheumatism and bone injuries and other medicines, cardiovascular and neurological drugs and others.
Executives
Tian Wen Shu Supervisors
Ai Ying Ping Director
Lei Qi Gang Executives
Hao Rui Zhi Directors, Directors, and Executives